MedPath
NMPA Approval

Thymopentin for Injection

国药准字H20093331

August 6, 2023

Drug Information

注射用胸腺五肽

注射剂

1mg

化学药品

August 6, 2023

Company Information

Applicant Company

杭州经济技术开发区一号大街1号

Manufacturing Company

杭州经济技术开发区一号大街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用胸腺五肽 - NMPA 批准文号 | MedPath